GERMANY - KfW joins other VCs in backing Protagen AG
Kreditanstalt für Wiederaufbau (KfW) has joined existing lead investors MIG AG and Co KG Beteiligungsfonds 3 and S-Venture Capital Dortmund GmbH in raising EUR 1m in interim financing for protein research company Protagen AG. This is the third round of funding for the company. Protagen is a provider of products, services and software solutions for protein research. Recently, Protagen has received a BioChance Plus grant from the German government to identify biomarkers for multiple sclerosis and rheumatoid arthritis. The company is headquartered in Dortmund, and has a second office in New Jersey, US. At present, it employs a staff of 25.
More on Early-stage
Osivax raises €33m from EIC and BPI France
Of the funding, €15m from EIC will count towards series-B funding, while the rest will be a grant
Alta Life Sciences, Kurma lead €3.5m series-A for Deepull
Axis Participaciones and Sofimac Innovation, through Pertinence Invest 2, also take part in the round
ETF leads €7m round for Basemark
Fresh capital will be used to accelerate Basemark's growth in the field of autonomous vehicles
Seventure, BioGeneration lead €18.5m round for Citryll
Pharma company has so far raised €33.5m from private backers
Latest News
Verdane acquires minority stake in Studytube for €10m
Company plans on expanding further into the learning and development market
Neva Finventures leads €3m round for Yolo
Primomiglio, Banca di Piacenza, Intesa Sanpaolo Vita, Be Shaping the Future and CRIF also take part in the round
Hayfin becomes majority shareholder in Frans Bonhomme
Centerbridge Partners, which invested in the company in 2013, retains a minority stake
Novo Holdings et al. in $20m round for Reapplix
Company will use the proceeds to commercialise its flagship product across the US